Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Stephany Y Tzeng"'
Autor:
Rawan Al‐Kharboosh, Alex Bechtle, Stephany Y. Tzeng, Jiaying Zheng, Sujan Kumar Mondal, David R. Wilson, Carlos Perez‐Vega, Jordan J. Green, Alfredo Quiñones‐Hinojosa
Publikováno v:
Bioengineering & Translational Medicine, Vol 9, Iss 6, Pp n/a-n/a (2024)
Abstract Confounding results of engineered mesenchymal stem cells (MSCs) used as cellular vehicles has plagued technologies whereby success or failure of novel approaches may be dismissed or inaccurately ascribed solely to the biotechnology platform
Externí odkaz:
https://doaj.org/article/564e9e2cb426416bac761d550052e0e0
Autor:
Raquel Lima e Silva, Adam C. Mirando, Stephany Y. Tzeng, Jordan J. Green, Aleksander S. Popel, Niranjan B. Pandey, Peter A. Campochiaro
Publikováno v:
iScience, Vol 26, Iss 2, Pp 106078- (2023)
Summary: AXT107, a collagen-derived peptide that binds integrins αvβ3 and α5β1 with high affinity, suppresses vascular endothelial growth factor (VEGF) signaling, promotes angiopoietin 2-induced Tie2 activation, and suppresses neovascularization
Externí odkaz:
https://doaj.org/article/78fca1949d7a467b812527971c29c555
Autor:
Yu Qin, Aumreetam Dinabandhu, Xuan Cao, Jaron Castillo Sanchez, Kathleen Jee, Murilo Rodrigues, Chuanyu Guo, Jing Zhang, Jordan Vancel, Deepak Menon, Noore-Sabah Khan, Tao Ma, Stephany Y. Tzeng, Yassine Daoud, Jordan J. Green, Gregg L. Semenza, Silvia Montaner, Akrit Sodhi
Publikováno v:
JCI Insight, Vol 7, Iss 13 (2022)
Most patients with neovascular age-related macular degeneration (nvAMD), the leading cause of severe vision loss in elderly US citizens, respond inadequately to current therapies targeting a single angiogenic mediator, vascular endothelial growth fac
Externí odkaz:
https://doaj.org/article/37d58f59bf7947c89a0277022b678898
Autor:
Elana Ben-Akiva, John W. Hickey, Randall A. Meyer, Ariel Isser, Sydney R. Shannon, Natalie K. Livingston, Kelly R. Rhodes, Alyssa K. Kosmides, Tiarra R. Warren, Stephany Y. Tzeng, Jonathan P. Schneck, Jordan J. Green
Publikováno v:
Acta Biomaterialia. 160:187-197
Autor:
Sarah Y. Neshat, Stuart J. Bauer, Kelly R. Rhodes, Victor M. Quiroz, Valerie W. Wong, Shirley M. Lowmaster, Stephany Y. Tzeng, Jordan J. Green, Joshua C. Doloff
Publikováno v:
ACS Biomaterials Science & Engineering.
Autor:
David R. Wilson, Stephany Y. Tzeng, Yuan Rui, Sarah Y. Neshat, Marranne J. Conge, Kathryn M. Luly, Ellen Wang, Jessica L. Firestone, Josie McAuliffe, Giulietta Maruggi, Rashmi Jalah, Russell Johnson, Joshua C. Doloff, Jordan J. Green
Publikováno v:
Advanced Therapeutics. 6
Autor:
Wen Tang, Jia Zhuang, Aaron C. Anselmo, Xian Xu, Aranda Duan, Ruojie Zhang, James L. Sugarman, Yingying Zeng, Evan Rosenberg, Tyler Graf, Kevin J. McHugh, Stephany Y. Tzeng, Adam M. Behrens, Lisa E. Freed, Lihong Jing, Surangi Jayawardena, Shelley B. Weinstock, Xiao Le, Christopher Sears, James Oxley, John L. Daristotle, Joe Collins, Robert Langer, Ana Jaklenec
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Food fortification is an effective strategy to address vitamin A (VitA) deficiency, which is the leading cause of childhood blindness and drastically increases mortality from severe infections. However, VitA food fortification remains challenging due
Autor:
Oluwaseun O. Akinduro, Paola Suarez-Meade, McKinley Roberts, Stephany Y. Tzeng, Rachel Sarabia-Estrada, Paula Schiapparelli, Emily S. Norton, Ziya L. Gokaslan, Panos Z. Anastasiadis, Hugo Guerrero-Cázares, Jordan J. Green, Alfredo Quiñones-Hinojosa
Publikováno v:
Journal of neurosurgery. Spine.
OBJECTIVE The vertebral column is the most common site for skeletal metastasis, often leading to debilitating pain and weakness. Metastatic cancer has unique genetic drivers that potentiate tumorigenicity. There is an unmet need for novel targeted th
Autor:
Hannah J. Vaughan, Camila G. Zamboni, Laboni F. Hassan, Nicholas P. Radant, Desmond Jacob, Ronnie C. Mease, Il Minn, Stephany Y. Tzeng, Kathleen L. Gabrielson, Pranshu Bhardwaj, Xin Guo, David Francisco, Martin G. Pomper, Jordan J. Green
Publikováno v:
Science advances. 8(29)
Hepatocellular carcinoma (HCC) develops predominantly in the inflammatory environment of a cirrhotic liver caused by hepatitis, toxin exposure, or chronic liver disease. A targeted therapeutic approach is required to enable cancer killing without cau